Author Correction: Trends in kinase drug discovery: targets, indications and inhibitor design.
Saved in:
| Title: | Author Correction: Trends in kinase drug discovery: targets, indications and inhibitor design. |
|---|---|
| Authors: | Attwood MM; Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden., Fabbro D; Cellestia Biotech, Basel, Switzerland., Sokolov AV; Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden., Knapp S; Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences, Frankfurt am Main, Germany.; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer network DKTK and Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany., Schiöth HB; Functional Pharmacology, Department of Neuroscience, Uppsala University, Uppsala, Sweden. helgi.schioth@neuro.uu.se.; Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia. helgi.schioth@neuro.uu.se. |
| Source: | Nature reviews. Drug discovery [Nat Rev Drug Discov] 2021 Oct; Vol. 20 (10), pp. 798. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
